Salt CompositionVerapamil 2.5mg
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Hypertension (high blood pressure) / Treatment of Angina (heart-related chest pain) / Treatment of Arrhythmia
Customers also bought
More About Vpl 2.5mg Injection
Benefits
In Treatment of Hypertension (high blood pressure) Vpl 2.5mg Injection works by relaxing blood vessels so that blood can flow more easily around your body. This lowers your blood pressure and reduces your risk of having a stroke, heart attack, or kidney problems in the future. It must be taken regularly as prescribed to be effective. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. Do not stop taking this medicine without your doctor?s advice, even if you feel well. In Treatment of Angina (heart-related chest pain) Vpl 2.5mg Injection helps treat heart-related chest pain (angina attack) as well as prevent it from happening in the future. However, it should not be used for acute attacks of angina. It works by relaxing and widening blood vessels in the heart. This makes it easier for blood to flow to the heart, so it gets more oxygen. This medicine thus helps to increase your ability to exercise and go about your daily life more easily and confidently. It should be taken regularly to be effective. Do not stop taking it without your doctor?s advice, even if you feel well. In Treatment of Arrhythmia Vpl 2.5mg Injection may also be used to treat abnormal heart rhythms (arrhythmia). It may help stop an abnormal rhythm while it is happening or prevent its occurrence in the first place.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
Vpl 2.5mg Injection is a calcium channel blocker. It blocks the action of calcium on the heart and blood vessels, thereby widening the blood vessels and allowing more blood and oxygen to reach the heart. This reduces blood pressure and decreases the chances of angina (chest pain).
Unsafe: Avoid consuming alcohol with Vpl 2.5mg Injection as it is deemed unsafe.
Seek medical advice from your doctor: Vpl 2.5mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Vpl 2.5mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Not Safe: Vpl 2.5mg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Caution Advised: Vpl 2.5mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Vpl 2.5mg Injection may be needed. Doctor consultation is advised. Careful monitoring of the patient for any signs of overdosage is advisable.
Caution Advised: Vpl 2.5mg Injection should be used with caution in patients with liver disease. Dose adjustment of Vpl 2.5mg Injection may be needed. Doctor consultation is advised.
Manufacturer Address
Samarth House, 168, Bangur Nagar, Off Link Road, Near Ayappa Temple & Kallol Kali Temple, Goregaon (W), Mumbai - 400 090.
References
Sampson KJ, Kass RS. Anti-Arrhythmic Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 831
Opie LH. Calcium Channel Blockers. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 73-78
Hume JR, Grant AO. Agents Used in Cardiac Arrhythmias. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 243
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1469-70
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (19 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
Verapamil (25 Jul. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
